Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Efficacy and Safety of Sirolimus, Everolimus or Mycophenolate in Renal Transplant Recipients Receiving Induction With Anti-thymocyte Globulin, Tacrolimus and Prednisone

NCT03468478 is registered in ClinicalTrials.gov with Hospital do Rim e Hipertensão as lead sponsor.

NCT NCT03468478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03468478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Efficacy and Safety of Sirolimus, Everolimus or Mycophenolate in Renal Transplant Recipients Receiving Induction With Anti-thymocyte Globulin, Tacrolimus and Prednisone
Lead sponsor
Hospital do Rim e Hipertensão
Phase
Phase 4
Overall status
Completed
Start date
June 18, 2017
Completion date
August 23, 2021
Enrollment
1,209 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant infection